Fiore Cannabis Ltd.
Marapharm intends to pursue commercial ventures in the medical marijuana business. We were established to enter the emerging market created by Canada’s Marihuana for Medical Purposes Regulations (“MMPR”). The Company is positioned as a pioneer and leader in this marketplace with plans to construct brand new facilities in British Columbia’s Okanagan Valley and rapidly expand them to meet strategic advantages for growth and market penetration. Our license is currently under review. Plans call for initial construction of a facility on 11 acres under lease to us with expansion plans to a 100,000 sq. foot facility in year two. Further construction is built into the Company’s long term growth strategy once a realistic assessment and export demand can be determined. Additional facility footage will at that point be brought forward. The Canadian market potential for medical marijuana is currently estimated at Cdn. $1.2 billion and the world market potential is estimated at Cdn. $115 billion. As a result, Marapharm is well positioned to enjoy significant and consistent revenue growth for many years.
Fiore Cannabis Ltd. (FIOR)
Communiqués de presse
Le 22 mars/March 2021
Fiore Cannabis Ltd. Warrants listed on February 21, 2018 expired January 31, 2021. The warrants will be delisted at the market close today.
Les bons de souscription de Fiore Cannabis Ltd. inscrits le 21 février 2018 ont expiré le 31 janvier 2021. Les bons de souscription seront radiés à la clôture du marché aujourd'hui.